Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 53
1996 64
1997 59
1998 71
1999 51
2000 59
2001 69
2002 72
2003 71
2004 168
2005 200
2006 179
2007 250
2008 407
2009 297
2010 486
2011 623
2012 306
2013 425
2014 297
2015 356
2016 373
2017 337
2018 289
2019 437
2020 120
Text availability
Article attribute
Article type
Publication date

Search Results

5,759 results
Results by year
Filters applied: . Clear all
Page 1
Potential Use of Human Stem Cell-Derived Intestinal Organoids to Study Inflammatory Bowel Diseases.
Dotti I and Salas A. Inflamm Bowel Dis 2018 - Review. PMID 30169820 Free PMC article.
Inflammatory bowel disease (IBD) is a chronic remitting disorder with increasing incidence worldwide. The intestinal epithelial barrier plays a major role in IBD, contributing to its pathogenesis, evolution, and perpetuation over time. ...
Inflammatory bowel disease (IBD) is a chronic remitting disorder with increasing incidence worldwide. The intestinal epithelial barri …
Acupuncture in Inflammatory Bowel Disease.
Song G, et al. Inflamm Bowel Dis 2019. PMID 30535303
Acupuncture has been shown to decrease disease activity and inflammation via increase of vagal activity in inflammatory bowel disease. ...Although the data from these trials are promising, more studies are needed given the heterogeneous and multifactorial aspects of inflammatory bowel disease. ...
Acupuncture has been shown to decrease disease activity and inflammation via increase of vagal activity in inflammatory bowel disease …
Low Frequency of Opportunistic Infections in Patients Receiving Vedolizumab in Clinical Trials and Post-Marketing Setting
Ng SC, et al. Inflamm Bowel Dis 2018 - Clinical Trial. PMID 30312414 Free PMC article.
BACKGROUND: Vedolizumab (ENTYVIO) is a humanized α4β7 integrin antagonist approved for the treatment of inflammatory bowel disease, which selectively blocks gut-specific lymphocyte trafficking. ...
BACKGROUND: Vedolizumab (ENTYVIO) is a humanized α4β7 integrin antagonist approved for the treatment of inflammatory bowel disease, w …
A State-of-the-Art Review of New and Emerging Therapies for the Treatment of IBD
Chudy-Onwugaje KO, et al. Inflamm Bowel Dis 2019. PMID 30445504 Free PMC article.
Over the last 2 decades, novel therapies targeting several immune pathways have been developed for the treatment of patients with inflammatory bowel disease (IBD). ...
Over the last 2 decades, novel therapies targeting several immune pathways have been developed for the treatment of patients with inflammato …
The Role of Cannabis in the Management of Inflammatory Bowel Disease: A Review of Clinical, Scientific, and Regulatory Information.
Swaminath A, et al. Inflamm Bowel Dis 2019 - Review. PMID 30358848
There is significant interest among patients and providers in using cannabis (marijuana) and its derivatives to treat a number of chronic illnesses, including inflammatory bowel disease. ...This white paper summarizes the preclinical data, clinical data, safety data, and the regulatory landscape as they apply to medical cannabis use in inflammatory bowel disease. ...
There is significant interest among patients and providers in using cannabis (marijuana) and its derivatives to treat a number of chronic il …
The Role of Early Biologic Therapy in Inflammatory Bowel Disease.
Berg DR, et al. Inflamm Bowel Dis 2019. PMID 30934053
The goals for treatment of inflammatory bowel diseases (IBDs) are changing from elimination of symptoms toward complete disease control-a process that demands both clinical and endoscopic remission. ...Recent studies suggest that the use of biologic agents, specifically those targeting tumor necrosis factor alpha, earlier in the treatment course improves patient outcomes and can prevent progression to irreversible bowel damage. ...
The goals for treatment of inflammatory bowel diseases (IBDs) are changing from elimination of symptoms toward complete disease contr …
The Mesenteric Fat and Intestinal Muscle Interface: Creeping Fat Influencing Stricture Formation in Crohn's Disease
Mao R, et al. Inflamm Bowel Dis 2019 - Review. PMID 30346528
Increasing evidence points to a link between creeping fat and intestinal inflammation in CD, where histopathologic evaluation shows a significant association between creeping fat and connective tissue changes in the bowel wall, such as muscular hypertrophy, fibrosis, and stricture formation. ...
Increasing evidence points to a link between creeping fat and intestinal inflammation in CD, where histopathologic evaluation shows a signif …
5,759 results
Jump to page
Feedback